VYZULTA

latanoprostene bunod · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VYZULTA, covering 2017-11-02 to 2018-06-11. Get the full timeline:

Most recent: FDA Approved: VYZULTA — Supplemental Application (Bausch & Lomb Incorporated)